{"nct_id":"NCT02573467","title":"An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203","status":"COMPLETED","status_verified_date":"2018-02","start_date":"2015-11-02","start_date_type":"ACTUAL","primary_completion_date":"2016-08-17","primary_completion_date_type":"ACTUAL","completion_date":"2017-02-13","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}